Sponsor or institution

Clinical trials and research at Candel Therapeutics, Inc.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Aglatimagene Besadenovec with Prodrug and Pembrolizumab vs Docetaxel for Advanced Non-Squamous NSCLC

  This phase 3 trial tests whether giving aglatimagene besadenovec with a prodrug and pembrolizumab works better than standard chemotherapy (docetaxel) for adults with stage IV non-squamous NSCLC that progressed on pembrolizumab.

  Recruiting Phase 3 Candel Therapeutics, Inc. · New York, New York · NCT07660094

• Biomarker testing in men with localized prostate cancer treated with aglatimagene besadenovec

  This study will test whether giving intraprostatic aglatimagene besadenovec with oral valacyclovir alongside radiation is safe and how the viral material and immune signals behave in men with intermediate‑risk localized prostate cancer.

  Recruiting at 7 sites Phase 2 Candel Therapeutics, Inc. · Peoria, Arizona and 6 other locations · NCT07332000

Quick answers

How many clinical trials run by Candel Therapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →